指南与共识乳腺乳腺X线MR

美国放射学会适宜性标准®女性乳腺癌筛查:2025年更新

ACR Appropriateness Criteria® Female Breast Cancer Screening: 2025 Update.
指南 / 共识 · J Am Coll Radiol · 2025-01-01

该指南按平均、中等和高风险三类人群给出乳腺癌筛查影像推荐:所有风险类别均推荐乳腺X线和数字乳腺断层合成筛查;高风险患者推荐从25至30岁起筛查乳腺MRI,乳腺X线和数字乳腺断层合成起始年龄视风险类型在25至40岁间变化。

要点

  • 所有风险类别均推荐乳腺X线和数字乳腺断层合成用于乳腺癌筛查。
  • 高风险患者推荐筛查乳腺MRI,起始年龄可早至25至30岁。
  • 高风险患者乳腺X线和数字乳腺断层合成起始年龄视风险类型在25至40岁间变化。

核心结论

  • 常规筛查通过早期发现可大幅降低乳腺癌死亡和疾病负担风险;筛查推荐因个体乳腺癌风险而异,风险常分为平均、中等和高风险三类。

研究设计与样本

  • 美国放射学会适宜性标准为针对特定临床情况的循证指南,由多学科专家组每年审查,系统分析同行评审期刊文献,采用GRADE等方法学原则评价证据,并依据RAND/UCLA适宜性方法用户手册确定影像与治疗程序的适宜性;文献缺乏或模棱两可时可由专家作为主要证据来源形成推荐。

诊断标准与关键数值

  • 对出生时指定为女性且具有原生乳腺组织者,所有风险类别均推荐乳腺X线和数字乳腺断层合成用于乳腺癌筛查。
  • 高风险患者推荐筛查乳腺MRI,起始年龄可早至25至30岁。
  • 高风险患者乳腺X线和数字乳腺断层合成的起始年龄视风险类型在25至40岁间变化。

局限性

  • 在同行评审文献缺乏或模棱两可的情况下,专家可能作为形成推荐的主要证据来源。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Routine screening substantially reduces the risk of mortality and morbidity of breast cancer with early detection. Multiple different imaging modalities may be used to screen for breast cancer. Screening recommendations differ based on an individual's risk of developing breast cancer. Numerous factors contribute to breast cancer risk, which is frequently divided into three major categories: average, intermediate, and high risk. For patients assigned female at birth with native breast tissue, mammography and digital breast tomosynthesis are recommended for breast cancer screening in all risk categories. In high-risk patients, screening with breast MRI is recommended starting as early as 25 to 30 years of age and mammography and digital breast tomosynthesis with a variable starting age between 25 and 40 years of age, depending on the type of risk. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision process support the systematic analysis of the medical literature from peer reviewed journals. Established methodology principles such as Grading of Recommendations Assessment, Development, and Evaluation or GRADE are adapted to evaluate the evidence. The RAND/UCLA Appropriateness Method User Manual provides the methodology to determine the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where peer reviewed literature is lacking or equivocal, experts may be the primary evidentiary source available to formulate a recommendation.

来源:J Am Coll Radiol,查看原文。版权归原作者所有。

引用

  1. Yeh ED, Brown A, Freer PE, et al. ACR Appropriateness Criteria® Female Breast Cancer Screening: 2025 Update. J Am Coll Radiol. 2025. PMID: 41193041. doi:10.1016/j.jacr.2025.08.044

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。